Due to an unforeseen conflict our December Quarterly will need to be postponed to
January 8, 2019
“A Deeper Response: MRD-Negativity Results for
Pre-B Acute Lymphoblastic Leukemia Patients Receiving Blinatumomab”
Christine Rimkus CNS-BC, MSN AOCN
Center for Blood and Marrow Outpatient Transplant,
SSM Health St. Louis University Hospital
- Understand the use of Blinatumomab (Blincyto) in the treatment of relapsed Pre-B Acute Lymphoblastic Leukemia.
- Describe the mechanism of action, dosing and administration, and important side effects for Blinatumomab for safe monitoring of patients receiving this type of immunotherapy.
- Discuss the patient/family education required to receive this agent in the outpatient setting.
Claim Jumper Restaurant
18050 Brookhurst Street Fountain Valley, CA 92708
Phone: (714) 963-6711
Parking is free and readily available
Upcoming Quarterly Lectures
March 12, 2019
December 10, 2019